Advertisement
Home Tags Health Costs

Tag: Health Costs

For cancer survivors

HDHPs Up Disparities in Access to Care Among Cancer Survivors

0
Cost barriers increased for blacks, with 22.8 percent reporting they skipped medications to save money
Over 1 percent of Americans purchase prescription medication from outside of the United States to save money

Roughly 2 Million Americans Buy Prescriptions From Outside the Country

0
Patient education, stringent quality control measures necessary to ensure safe purchases
The United States' deal with Gilead Sciences to scoop up nearly all of the world's supply of the only drug licensed to treat COVID-19 has outraged health experts.

U.S. Grab of Only COVID-19 Treatment Outrages Health Experts

0
Behavior sets a dangerous precedent for attempts to share scarce treatments during the pandemic, experts warn
Primary care practices are estimated to lose more than $67

Large Losses Anticipated for Primary Care Practices in 2020

0
Loss of gross revenue over 2020 due to COVID-19 estimated at $67,774 per full-time physician
Gilead Sciences

COVID-19 Drug Remdesivir Could Cost Up to $3,120 Per Patient

0
In the U.S., government programs, additional Gilead assistance should mean all patients have access to the drug
COVID-19 hospitalizations could result in high out-of-pocket spending for commercially insured consumer-directed health plan enrollees

Costs for COVID-19 High With Consumer-Directed Health Plans

0
Out-of-pocket costs high for consumer-directed health plan enrollees, especially younger individuals
Higher medical and nonmedical financial hardships are associated with a greater number of emergency department visits and lower receipt of some preventive services among cancer survivors

Financial Hardship Linked to More ED Visits in Cancer Survivors

0
Medical financial hardship linked to lower uptake of influenza vaccine, lower breast cancer screening
The U.S. government does not have the legal authority to force drug companies to disclose prices in their TV ads

Court Rules Against Drug Price Disclosures in TV Ads

0
Judges said HHS exceeded its legal authority by requiring drug price disclosure as part of its stewardship of Medicare, Medicaid
Greater health system use and higher costs are seen with nine months of isoniazid compared with four months of rifampin in both adults and children treated for latent tuberculosis infection

Four Months of Rifampin Costs Less Than Nine Months Isoniazid

0
Health system use and costs higher for nine months of isoniazid in adults and children in all settings
The national costs attributed to medical care for cancer are considerable and are projected to increase 34 percent by 2030 based on population growth

Considerable National Costs Attributed to Cancer Medical Care

0
Overall annualized average costs highest for end-of-life cancer phase followed by initial, continuing phases